In 2026, how many distinct formularies will Medicare Advantage Part D (MAPD) plans adopt?

In 2026, Medicare Advantage Part D (MAPD) plans are set to adopt five distinct formularies. This aligns with the ongoing efforts to standardize and simplify drug coverage options for beneficiaries, facilitating easier navigation of their prescription drug benefits. Each formulary is structured to accommodate various tiers of medications, with distinct coverage rules and cost-sharing for different types of drugs, ensuring comprehensive access to necessary treatments. The implementation of five formularies provides the flexibility for plans to tailor their offerings while adhering to federal regulations, ultimately enabling better medication management for members.

Understanding the number of formularies is essential for anyone involved in the administration or enrollment in MAPD plans, as it directly impacts the prescription coverage options available to beneficiaries and their potential out-of-pocket costs.